Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Guerzoni

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 10, 2022
The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraineSimona Guerzoni, Carlo Baraldi, Luca Pani
Drug and Alcohol Review|May 19, 2026
Calcitonin Gene-Related Peptide Signalling in Alcohol Use Disorders: A Scoping ReviewLanfranco Pellesi, Taibah Ali Ahmad, Simona Guerzoni
Drug, Healthcare and Patient Safety|December 1, 2021
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid ReviewFlavia Lo Castro, Simona Guerzoni, Lanfranco Pellesi
Clinical Pharmacology in Drug Development|April 15, 2017
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to DateLanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini
Therapeutics and Clinical Risk Management|May 3, 2019
Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapyChiara Lupi, Simona Guerzoni, Andrea Negro, et al.
Journal of Clinical Medicine|March 25, 2022
Clinical Evidence of Cannabinoids in Migraine: A Narrative ReviewFlavia Lo Castro, Carlo Baraldi, Lanfranco Pellesi, et al.
Pharmacological Research|May 3, 2018
Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive reviewSimona Guerzoni, Lanfranco Pellesi, Luigi Alberto Pini, et al.
The Journal of Headache and Pain|May 6, 2016
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatmentSimona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 5, 2019
Pharmacokinetics and pharmacodynamics of new acute treatments for migraineChiara Lupi, Silvia Benemei, Simona Guerzoni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2023
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life studySimona Guerzoni, Flavia Lo Castro, Daria Brovia, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 10, 2022
The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraineSimona Guerzoni, Carlo Baraldi, Luca Pani
Drug and Alcohol Review|May 19, 2026
Calcitonin Gene-Related Peptide Signalling in Alcohol Use Disorders: A Scoping ReviewLanfranco Pellesi, Taibah Ali Ahmad, Simona Guerzoni
Drug, Healthcare and Patient Safety|December 1, 2021
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid ReviewFlavia Lo Castro, Simona Guerzoni, Lanfranco Pellesi
Clinical Pharmacology in Drug Development|April 15, 2017
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to DateLanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini
Therapeutics and Clinical Risk Management|May 3, 2019
Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapyChiara Lupi, Simona Guerzoni, Andrea Negro, et al.
Journal of Clinical Medicine|March 25, 2022
Clinical Evidence of Cannabinoids in Migraine: A Narrative ReviewFlavia Lo Castro, Carlo Baraldi, Lanfranco Pellesi, et al.
Pharmacological Research|May 3, 2018
Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive reviewSimona Guerzoni, Lanfranco Pellesi, Luigi Alberto Pini, et al.
The Journal of Headache and Pain|May 6, 2016
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatmentSimona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 5, 2019
Pharmacokinetics and pharmacodynamics of new acute treatments for migraineChiara Lupi, Silvia Benemei, Simona Guerzoni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2023
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life studySimona Guerzoni, Flavia Lo Castro, Daria Brovia, et al.
Pageof 8